MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 55 filers reported holding MAGENTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $15,033 | -90.5% | 38,059 | -65.9% | 0.00% | – |
Q3 2022 | $158,000 | +7.5% | 111,761 | -8.7% | 0.00% | – |
Q2 2022 | $147,000 | -68.7% | 122,387 | -24.5% | 0.00% | – |
Q1 2022 | $470,000 | -43.3% | 162,079 | -13.3% | 0.00% | – |
Q4 2021 | $829,000 | -33.8% | 187,020 | +8.8% | 0.00% | – |
Q3 2021 | $1,252,000 | -16.5% | 171,871 | +12.2% | 0.00% | – |
Q2 2021 | $1,499,000 | +105.3% | 153,225 | +148.8% | 0.00% | – |
Q1 2021 | $730,000 | +20.1% | 61,584 | -20.6% | 0.00% | – |
Q4 2020 | $608,000 | -5.1% | 77,558 | -17.7% | 0.00% | – |
Q3 2020 | $641,000 | +10.9% | 94,236 | +22.4% | 0.00% | – |
Q2 2020 | $578,000 | +114.9% | 76,989 | +79.6% | 0.00% | – |
Q1 2020 | $269,000 | -20.6% | 42,874 | +91.8% | 0.00% | – |
Q4 2019 | $339,000 | +50.0% | 22,348 | +1.4% | 0.00% | – |
Q3 2019 | $226,000 | -36.9% | 22,035 | -9.2% | 0.00% | – |
Q2 2019 | $358,000 | -22.3% | 24,274 | -13.4% | 0.00% | – |
Q1 2019 | $461,000 | +339.0% | 28,018 | +52.7% | 0.00% | – |
Q4 2018 | $105,000 | -89.7% | 18,343 | -75.7% | 0.00% | – |
Q2 2018 | $1,019,000 | – | 75,504 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 8,008,204 | $121,404,000 | 75.69% |
Casdin Capital, LLC | 3,098,121 | $46,968,000 | 4.32% |
Alphabet Inc. | 3,339,138 | $50,621,000 | 3.06% |
Eventide Asset Management | 3,393,894 | $51,451,000 | 1.45% |
Opaleye Management Inc. | 449,950 | $6,728,000 | 1.32% |
GILDER GAGNON HOWE & CO LLC | 4,103,425 | $62,208,000 | 0.65% |
HARVARD MANAGEMENT CO INC | 332,610 | $5,042,000 | 0.53% |
Values First Advisors, Inc. | 21,844 | $331,000 | 0.32% |
MYDA Advisors LLC | 22,000 | $334,000 | 0.15% |
Aries Wealth Management | 12,000 | $177,000 | 0.11% |